i-ImmunDx™ Platform and POCT Products
Seinda’s proprietary i-ImmunDx™ platform is specifically designed for ophthalmic point-of-care applications. The i-ImmunDx™ platform is the basis for the development of Seinda’s series of point-of-care testing (POCT) products. Our line of POCT products help facilitate clinical diagnosis, aid treatment selection, and monitor disease status.
COVID-19 Antigen Test
CoVisAg is Seinda’s rapid POC antigen test for COVID-19. As a lateral flow immunoassay, CoVisAg provides quick and easy detection of SARS-CoV-2antigens directly at patient point-of-care within 30 minutes of sample collection.
Seinda’s new drug pipeline focuses on ocular disorders that currently have large unmet needs, including dry eye, inflammatory eye diseases, and vision problems such as presbyopia and myopia.